Article
Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients.
Medicine - 14 Jul 2023
Mohamed Abdelnajid Doaa, Elmowafy Ahmed Y, Rostaing Lionel, Elrakaiby Marwa T
Abstract excerpt
Some hepatitis-C virus patients have resistance to direct-acting-antivirals (DAAs). Genetic polymorphisms have been associated with drug resistance. This study aimed to evaluate the role of interleukin (IL)-28B gene polymorphism and IL-12 levels as predictors for a response to sofosbuvir/ribavirin (SOF/RBV) with (triple-therapy) or without (dual-therapy) Peg-alpha-interferon. 92 hepatitis C virus (HCV)/RNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.